To assess drug release, we applied FITC-conjugated D-CuP hydrogel to the wounds and measured the fluorescence signal of the residual hydrogel at predetermined time intervals in darkness
As her dosage gradually increased, her progress remained steady
Patients with type 2 diabetes, treated with metformin alone or treated with metformin and a second OAD treatment that could be a sulfonylurea or a glinide or a sodium-glucose cotransporter-2 (SGLT-2) inhibitor or a dipeptidyl peptidase-4 (DPP-4) inhibitor, and who were not adequately controlled with this treatment (HbA1c range 7.5% to 10% for patients previously treated with metformin alone and 7% to 9% for patients previously treated with metformin and a second OAD treatment) entered a run-in period for 4 weeks
Common Reactions: Gastrointestinal discomfort, such as nausea, vomiting, and diarrhea
PMID: 29 AtzeniFGerratanaEFrancesco MasalaIBongiovanniSSarzi-PuttiniPRodrguez-CarrioJ
Absorption of L-carnitine dietary supplements (0.5-6 g) is primarily passive